US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 132 actively recruiting studies with Louisiana sites out of 132 registered in total. The busiest research areas in Louisiana are Obesity, Overweight, Hypertension. Leading sponsors running trials in the state include Pennington Biomedical Research Center, AstraZeneca, Tulane University. By stage, Louisiana trials break down as Phase 1 (10), Phase 2 (27), Phase 3 (57), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
132
Recruiting Now
132
← Back to US Map
Top Conditions in Louisiana
Obesity (7)Overweight (4)Hypertension (3)Systemic Sclerosis (3)Healthy (2)Ulcerative Colitis (2)Multiple Myeloma (2)Non-small Cell Lung Cancer (2)Colorectal Cancer (CRC) (2)Crohn's Disease (2)Pancreatic Adenocarcinoma (2)Asthma (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 132 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 132. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Obesity, Overweight, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT04907396 N/A
Recruiting
International Weight Control Registry
Condition
Weight Loss
Enrollment
100,000 pts
Location
United States
Sponsor
Tufts University
View Trial →
NCT07684235 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
3,200 pts
Location
United States, Australia, Japan
Sponsor
Amgen
View Trial →
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT06466876 N/A
Recruiting
Retrieval-Based Word Learning in Autistic Children
Condition
Autism Spectrum Disorder
Enrollment
64 pts
Location
United States
Sponsor
Louisiana State University and
View Trial →
NCT07477704 Phase 2
Recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult P...
Condition
Hypercholesterolemia
Enrollment
420 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06842498 Phase 2
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
75 pts
Location
United States
Sponsor
Kyntra Bio
View Trial →
NCT07196748 Phase 3
Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Mode...
Condition
Colitis, Ulcerative
Enrollment
882 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT05379985 Phase 1, Phase 2
Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Muta...
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
754 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
View Trial →
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT05659381 Phase 3
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary P...
Condition
Stage III Ovarian Cancer
Enrollment
220 pts
Location
United States
Sponsor
GOG Foundation
View Trial →
NCT06388967 N/A
Recruiting
Pancreatic Cancer Detection Consortium
Condition
Pancreatic Cancer
Enrollment
2,000 pts
Location
United States, Japan, South Korea
Sponsor
City of Hope Medical Center
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05168163 Phase 2
Recruiting
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of U...
Condition
Locally Advanced Hepatocellular Carcinoma
Enrollment
122 pts
Location
United States
Sponsor
Academic and Community Cancer
View Trial →
NCT05737121 Phase 2
Recruiting
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidoc...
Condition
Interstitial Cystitis
Enrollment
120 pts
Location
United States
Sponsor
Vaneltix Pharma, Inc.
View Trial →
NCT05263206 Phase 3
Recruiting
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Partici...
Condition
Pruritus
Enrollment
284 pts
Location
United States, Argentina, Canada
Sponsor
Sanofi
View Trial →
NCT06311214 Phase 2
Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing fo...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07690371 Phase 3
Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age W...
Condition
Moderate-to-Severe Atopic Dermatitis
Enrollment
510 pts
Location
United States
Sponsor
Nektar Therapeutics
View Trial →
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participant...
Condition
B-cell Malignancy
Enrollment
645 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
View Trial →
NCT07497087 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Condition
Systemic Sclerosis
Enrollment
448 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With N...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
303 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT05648214 Phase 1, Phase 2
Recruiting
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adu...
Condition
Healthy Volunteers
Enrollment
172 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06998940 Phase 3
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Adva...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04920617 Phase 2
Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosp...
Condition
Relapsed Diffuse Large B-cell Lymphoma
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
ImmunoVaccine Technologies, In
View Trial →
Page 2 of 6 — 132 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology